Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
VeriSIM Life utilizes AI to enhance drug discovery and development processes, aiming to improve patient outcomes by predicting the success of drug candidates. Their innovative platform, BIOiSIM, allows for advanced simulations and insights, minimizing waste and inefficiencies in drug development.
Claim this profile to keep your information accurate and add what's missing.
An AI-driven decision engine that facilitates drug discovery and R&D de-risking through predictive analytics and simulation capabilities.
A service that identifies licensable candidates for preclinical translation and out-licensing to commercialization partners.
BIOiSIM is an AI-driven platform that accelerates drug discovery by providing predictive analytics and simulation capabilities for drug candidates.
VeriSIM Life's services are designed for pharmaceutical companies, biotechs, and academic research institutions looking to enhance their drug development processes.
The mission of VeriSIM Life is to eliminate inaccuracy and waste in drug development, ensuring that promising drug candidates are identified and advanced efficiently.
VeriSIM Life was founded in 2017.
VeriSIM Life is headquartered in San Francisco, CA.